Immunome Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 2.72, 60.23, 219.82, 427.84, 634.39 ], "ebit_estimate": [ -263.3, -274.77, -154.33, -12.31, 152.43 ], "ebitda_estimate": [ -253.01, -255.66, 40.39, null, null ], "net_income_estimate": [ -244.17, -259.06, -138.85, -8.79, 151.53 ], "per_share_eps_estimate": [ -2.16, -2.18, -1.24, -0.09, 1.08 ], "eps_nri_estimate": [ -2.16, -2.18, -1.2, -0.08, 1.16 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ -246.97, -261.68, -151.9, -20.29, 128.9 ], "operating_cash_flow_per_share_estimate": [ -1.71, -1.57, null, null, null ], "roa_estimate": [ -32.5, -28.4, null, null, null ], "roe_estimate": [ -35.4, -31, null, null, null ], "gross_margin_estimate": [ null, 59, 59.5, 57, 54.2 ], "operating_cash_flow_estimate": [ -193.46, -177.63, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 21.62 ], "long_term_growth_rate_mean": 19.36, "long_term_revenue_growth_rate_mean": "264.89", "future_per_share_eps_estimate_growth": 18.17, "future_eps_nri_estimate_growth": 19.36, "future_revenue_estimate_growth": 264.89, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 0.18, 0.18, 2.6, 5.5, 10.66, 18.02, 25.66 ], "ebit_estimate": [ -64.25, -69.1, -72.62, -74.68, -71.43, -67.87, -63.47 ], "ebitda_estimate": [ -62.15, -67.33, -71.75, -88.76, null, null, null ], "net_income_estimate": [ -60.28, -65, -69.1, -66.87, -68.17, -64.77, -60.57 ], "per_share_eps_estimate": [ -0.52, -0.56, -0.59, -0.56, -0.54, -0.51, -0.57 ], "eps_nri_estimate": [ -0.52, -0.56, -0.59, -0.59, -0.54, -0.51, -0.57 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -60.2, -65.11, -69.05, -66.87, -68.17, -64.77, -60.57 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ 100, 100, null, 100, 100, 88, 88 ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 19.36, "long_term_revenue_growth_rate_mean": "264.89", "future_per_share_eps_estimate_growth": 18.17, "future_eps_nri_estimate_growth": 19.36, "future_revenue_estimate_growth": 264.89, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }